Welcome to LookChem.com Sign In|Join Free

CAS

  • or
C21H23NO4 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1446655-22-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1446655-22-6 Structure
  • Basic information

    1. Product Name: C21H23NO4
    2. Synonyms: C21H23NO4
    3. CAS NO:1446655-22-6
    4. Molecular Formula:
    5. Molecular Weight: 353.418
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1446655-22-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C21H23NO4(CAS DataBase Reference)
    10. NIST Chemistry Reference: C21H23NO4(1446655-22-6)
    11. EPA Substance Registry System: C21H23NO4(1446655-22-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1446655-22-6(Hazardous Substances Data)

1446655-22-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1446655-22-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,6,6,5 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1446655-22:
(9*1)+(8*4)+(7*4)+(6*6)+(5*6)+(4*5)+(3*5)+(2*2)+(1*2)=176
176 % 10 = 6
So 1446655-22-6 is a valid CAS Registry Number.

1446655-22-6Relevant articles and documents

HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE

-

Page/Page column 163, (2013/07/19)

The present invention relates to heterocyclic compounds useful for antagonising angiotensin II Type 2 (AT2) receptor. More particularly the invention relates to pyrrolidine and azetidine compounds, compositions containing them and their use in methods of treating or preventing disorders or diseases associated with AT2 receptor function including neuropathic pain, inflammatory pain, conditions associated with neuronal hypersensitivity, impaired nerve conduction velocity, cell proliferation disorders, disorders associated with an imbalance between bone resorption and bone formation and disorders associated with aberrant nerve regeneration.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1446655-22-6